Genetic control of t cell tolerance and susceptibility to autoimmune disease

Genetic Predisposition to Disease

Volumn , Issue , 2008, Pages 39-71

  Makaroff, Lydia ^a   Linterman, Michelle ^b   Liston, Adrian ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863960687     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (278)

1. Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M. & Tuomilehto, J. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52, 1052-1055 (2003).
2. Silman, A.J. et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32, 903-907 (1993).
3. Hansen, T. et al. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler 11, 504-510 (2005).
4. Deapen, D. et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35, 311-318 (1992).
5. Brix, T.H., Christensen, K., Holm, N.V., Harvald, B. & Hegedus, L. A populationbased study of Graves' disease in Danish twins. Clin Endocrinol (Oxf) 48, 397-400 (1998).
6. Brix, T.H., Kyvik, K.O. & Hegedus, L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85, 536-539 (2000).
7. Orholm, M., Binder, V., Sorensen, T.I., Rasmussen, L.P. & Kyvik, K.O. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 35, 1075-1081 (2000).
8. Park, Y.S., Kim, T.W., Kim, W.B. & Cho, B.Y. Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes. Korean J Intern Med 15, 202-210 (2000).
9. Binder, A., Maddison, P.J., Skinner, P., Kurtz, A. & Isenberg, D.A. Sjogren's syndrome: association with type-1 diabetes mellitus. Br J Rheumatol 28, 518-520 (1989).
10. Poulain, C., Johanet, C., Delcroix, C., Levy-Marchal, C. & Tubiana-Rufi, N. Prevalence and clinical features of celiac disease in 950 children with type 1 diabetes in France. Diabetes Metab 33, 453-458 (2007).
11. Cruz, A.A., Akaishi, P.M., Vargas, M.A. & de Paula, S.A. Association between thyroid autoimmune dysfunction and non-thyroid autoimmune diseases. Ophthal Plast Reconstr Surg 23, 104-108 (2007).
12. Sategna-Guidetti, C. et al. Autoimmune thyroid diseases and coeliac disease. Eur J Gastroenterol Hepatol 10, 927-931 (1998).
13. Zelissen, P.M., Bast, E.J. & Croughs, R.J. Associated autoimmunity in Addison's disease. J Autoimmun 8, 121-130 (1995).
14. Niederwieser, G. et al. Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 250, 672-675 (2003).
15. Mihailova, D. et al. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Adv Exp Med Biol 455, 55-60 (1999).
16. Anaya, J.M. et al. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 26, 208-214 (2006).
17. Anaya, J.M., Tobon, G.J., Vega, P. & Castiblanco, J. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J Rheumatol 33, 2227-2234 (2006).
18. Cataldo, F. & Marino, V. Increased prevalence of autoimmune diseases in firstdegree relatives of patients with celiac disease. J Pediatr Gastroenterol Nutr 36, 470-473 (2003).
19. Broadley, S.A., Deans, J., Sawcer, S.J., Clayton, D. & Compston, D.A. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 123 (Pt 6), 1102-1111 (2000).
20. Prahalad, S., Shear, E.S., Thompson, S.D., Giannini, E.H. & Glass, D.N. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum 46, 1851-1856 (2002).
21. Martin, V., Lee, L.A., Askanase, A.D., Katholi, M. & Buyon, J.P. Long-term followup of children with neonatal lupus and their unaffected siblings. Arthritis Rheum 46, 2377-2383 (2002).
22. Ginn, L.R. et al. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum 41, 400-405 (1998).
23. Vella, A. et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76, 773-779 (2005).
24. Brand, O.J. et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) 66, 508-512 (2007).
25. Hafler, D.A. et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357, 851-862 (2007).
26. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
27. Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36, 337-338 (2004).
28. Velaga, M.R. et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89, 5862-5865 (2004).
29. Harley, J.B. et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40, 204-210 (2008).
30. Begovich, A.B. et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75, 330-337 (2004).
31. Thorsby, E. & Lie, B.A. HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol 14, 175-182 (2005).
32. Zhernakova, A. et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 81, 1284-1288 (2007).
33. Tsurumaru, M. et al. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population. J Clin Endocrinol Metab 91, 3138-3143 (2006).
34. Todd, J.A. et al. Robust associations of four new chromosome regions from genomewide analyses of type 1 diabetes. Nat Genet 39, 857-864 (2007).
35. Motohashi, Y. et al. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab 88, 3137-3140 (2003).
36. Kochi, Y. et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37, 478-485 (2005).
37. Remmers, E.F. et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357, 977-986 (2007).
38. Mulcahy, B. et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 59, 676-683 (1996).
39. Tokuhiro, S. et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35, 341-348 (2003).
40. Okamoto, K. et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 72, 303-312 (2003).
41. Swanberg, M. et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37, 486-494 (2005).
42. Kurylowicz, A., Ramos-Lopez, E., Bednarczuk, T. & Badenhoop, K. Vitamin Dbinding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp Clin Endocrinol Diabetes 114, 329-335 (2006).
43. Smerdel, A. et al. Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene. Genes Immun 5, 310-312 (2004).
44. Sigurdsson, S. et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 56, 2202-2210 (2007).
45. You, C.G. et al. Association of interleukin-1 genetic polymorphisms with the risk of rheumatoid arthritis in Chinese population. Clin Chem Lab Med 45, 968-971 (2007).
46. Pawlik, A. et al. Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis. Tissue Antigens 67, 415-418 (2006).
47. Gregory, S.G. et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39, 1083-1091 (2007).
48. Teutsch, S.M., Booth, D.R., Bennetts, B.H., Heard, R.N. & Stewart, G.J. Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis. Eur J Hum Genet 11, 509-515 (2003).
49. Zhang, Z. et al. Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun 6, 145-152 (2005).
50. Jacobsen, M. et al. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet 26, 495-499 (2000).
51. Zhou, Q. et al. CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci U S A 100, 15041-15046 (2003).
52. Tienari, P.J., Wikstrom, J., Sajantila, A., Palo, J. & Peltonen, L. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet 340, 987-991 (1992).
53. Harbo, H.F., Celius, E.G., Vartdal, F. & Spurkland, A. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 53, 106-110 (1999).
54. Dai, K.Z. et al. The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun 2, 263-268 (2001).
55. Mycko, M.P., Kwinkowski, M., Tronczynska, E., Szymanska, B. & Selmaj, K.W. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol 44, 70-75 (1998).
56. Kristjansdottir, G. et al. Interferon Regulatory Factor 5 (IRF5) Gene Variants are Associated with Multiple Sclerosis in Three Distinct Populations. J Med Genet (2008).
57. Hockertz, M.K., Paty, D.W. & Beall, S.S. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls. Am J Hum Genet 62, 373-385 (1998).
58. Saarela, J. et al. PRKCA and multiple sclerosis: association in two independent populations. PLoS Genet 2, e42 (2006).
59. Graham, R.R. et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104, 6758-6763 (2007).
60. Gaffney, P.M. et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci U S A 95, 14875-14879 (1998).
61. Lee, Y.H., Harley, J.B. & Nath, S.K. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet 116, 361-367 (2005).
62. Wu, J. et al. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98, 1107-1113 (1996).
63. Kyogoku, C. et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46, 1242-1254 (2002).
64. Shin, H.D. et al. Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum Mol Genet 13, 2343-2350 (2004).
65. Lee-Kirsch, M.A. et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39, 1065-1067 (2007).
66. Wang, L. et al. A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet 3, e49 (2007).
67. Ye, D. et al. A novel single-nucleotide polymorphism of the Fcgamma receptor IIIa gene is associated with genetic susceptibility to systemic lupus erythematosus in Chinese populations: a family-based association study. Clin Exp Dermatol 31, 553-557 (2006).
68. Lin, Y.J. et al. A/C polymorphism in the interleukin-18 coding region among Taiwanese systemic lupus erythematosus patients. Lupus 17, 124-127 (2008).
69. Burton, P.R. et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39, 1329-1337 (2007).
70. Jacobson, E.M. & Tomer, Y. The genetic basis of thyroid autoimmunity. Thyroid 17, 949-961 (2007).
71. Ban, Y., Taniyama, M. & Ban, Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 85, 4639-4643 (2000).
72. Hadj Kacem, H. et al. PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study. J Clin Endocrinol Metab 88, 2274-2280 (2003).
73. Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
74. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39, 207-211 (2007).
75. Brant, S.R. et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73, 1282-1292 (2003).
76. Fowler, E.V. et al. TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J Med Genet 42, 523-528 (2005).
77. Parkes, M. et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39, 830-832 (2007).
78. Peltekova, V.D. et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36, 471-475 (2004).
79. Urcelay, E. et al. MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis 12, 33-37 (2006).
80. Dideberg, V. et al. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 16, 3008-3016 (2007).
81. Stoll, M. et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36, 476-480 (2004).
82. Kappler, J.W., Roehm, N. & Marrack, P. T cell tolerance by clonal elimination in the thymus. Cell 49, 273-280 (1987).
83. Villunger, A. et al. Negative selection of semimature CD4(+)8(-)HSA+ thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling. Proc Natl Acad Sci U S A 101, 7052-7057 Epub 2004 Apr 7026 (2004).
84. Bouillet, P. et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922-926. (2002).
85. Hanahan, D. Peripheral-antigen-expressing cells in thymic medulla: factors in selftolerance and autoimmunity. Curr Opin Immunol 10, 656-662 (1998).
86. Kyewski, B., Derbinski, J., Gotter, J. & Klein, L. Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol 23, 364-371 (2002).
87. Wicker, L.S., Todd, J.A. & Peterson, L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13, 179-200. (1995).
88. Baker, D., Rosenwasser, O.A., O'Neill, J.K. & Turk, J.L. Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol 155, 4046-4051 (1995).
89. Oldenborg, P.A., Gresham, H.D., Chen, Y., Izui, S. & Lindberg, F.P. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood 99, 3500-3504 (2002).
90. Boulard, O. et al. Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J Immunol 168, 4192-4201 (2002).
91. Zaccone, P. et al. Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I. Eur J Immunol 32, 1021-1028 (2002).
92. Braley-Mullen, H., Sharp, G.C., Medling, B. & Tang, H. Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Autoimmun 12, 157-165 (1999).
93. Rivero, V.E., Cailleau, C., Depiante-Depaoli, M., Riera, C.M. & Carnaud, C. Nonobese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). J Autoimmun 11, 603-610 (1998).
94. Takahashi, M. et al. High incidence of autoimmune dacryoadenitis in male nonobese diabetic (NOD) mice depending on sex steroid. Clin Exp Immunol 109, 555-561 (1997).
95. Ridgway, W.M., Fasso, M., Lanctot, A., Garvey, C. & Fathman, C.G. Breaking selftolerance in nonobese diabetic mice. J Exp Med 183, 1657-1662. (1996).
96. Baxter, A.G. et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 83, 227-231 (1994).
97. Vyse, T.J. & Todd, J.A. Genetic analysis of autoimmune disease. Cell 85, 311-318 (1996).
98. Kishimoto, H. & Sprent, J. A defect in central tolerance in NOD mice. Nat Immunol 2, 1025-1031. (2001).
99. Lesage, S. et al. Failure to censor forbidden clone of CD4 T cells in autoimmune diabetes. J Exp Med 196, 1175-1188 (2002).
100. Choisy-Rossi, C.M., Holl, T.M., Pierce, M.A., Chapman, H.D. & Serreze, D.V. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC genecontrolled near death experience. J Immunol 173, 3791-3800 (2004).
101. Liston, A. et al. Generalised resistance to thymic deletion in the NOD mouse: a polygenic trait characterized by defective induction of Bim. Immunity 21, 817-830 (2004).
102. Zucchelli, S. et al. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 22, 385-396 (2005).
103. Serreze, D.V. et al. Through Regulation of TCR Expression Levels, an Idd7 Region Gene(s) Interactively Contributes to the Impaired Thymic Deletion of Autoreactive Diabetogenic CD8+ T Cells in Nonobese Diabetic Mice. J Immunol 180, 3250-3259 (2008).
104. Liston, A. et al. Impairment of organ-specific T cell negative selection by diabetes susceptibility genes: genomic analysis by mRNA profiling. Genome Biol 8, R12 (2007).
105. Roifman, C.M., Gu, Y. & Cohen, A. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome. J Allergy Clin Immunol 117, 897-903 (2006).
106. Giliani, S. et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr 148, 272-274 (2006).
107. Shibata, F. et al. Skin infiltration of CD56(bright) CD16(-) natural killer cells in a case of X-SCID with Omenn syndrome-like manifestations. Eur J Haematol 79, 81-85 (2007).
108. Santagata, S., Villa, A., Sobacchi, C., Cortes, P. & Vezzoni, P. The genetic and biochemical basis of Omenn syndrome. Immunol Rev 178, 64-74 (2000).
109. Aleman, K., Noordzij, J.G., de Groot, R., van Dongen, J.J. & Hartwig, N.G. Reviewing Omenn syndrome. Eur J Pediatr 160, 718-725 (2001).
110. Enders, A. et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol 176, 5060-5068 (2006).
111. Toyabe, S., Watanabe, A., Harada, W., Karasawa, T. & Uchiyama, M. Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Sykdependent T-cell receptor signalling. Immunology 103, 164-171 (2001).
112. Shovlin, C.L. et al. Adult presentation of adenosine deaminase deficiency. Lancet 341, 1471 (1993).
113. Hirschhorn, R., Yang, D.R., Israni, A., Huie, M.L. & Ownby, D.R. Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery. Am J Hum Genet 55, 59-68 (1994).
114. Hirschhorn, R. et al. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 13, 290-295 (1996).
115. Khiong, K. et al. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J Clin Invest 117, 1270-1281 (2007).
116. Marrella, V. et al. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest 117, 1260-1269 (2007).
117. Sakaguchi, N. et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426, 454-460 (2003).
118. Siggs, O.M. et al. Opposing Function of the T Cell Receptor Kinase ZAP-70 in Immunity and Tolerance Differentially Titrate in Response to Nucleotide Substitutions. Immunity 27, 912-926 (2007).
119. Venanzi, E.S., Gray, D.H., Benoist, C. & Mathis, D. Lymphotoxin pathway and Aire influences on thymic medullary epithelial cells are unconnected. J Immunol 179, 5693-5700 (2007).
120. Gray, D.H. et al. Controlling the thymic microenvironment. Curr Opin Immunol 17, 137-143 (2005).
121. Zhu, M., Chin, R.K., Tumanov, A.V., Liu, X. & Fu, Y.X. Lymphotoxin receptor is required for the migration and selection of autoreactive T cells in thymic medulla. J Immunol 179, 8069-8075 (2007).
122. Fazekas de St Groth, B. DCs and peripheral T cell tolerance. Semin Immunol 13, 311-322 (2001).
123. Vang, T. et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-offunction variant. Nat Genet 37, 1317-1319 (2005).
124. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
125. Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330-336 (2003).
126. Khattri, R., Cox, T., Yasayko, S.A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4, 337-342 (2003).
127. Kim, J.M., Rasmussen, J.P. & Rudensky, A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8, 191-197 (2007).
128. Jordan, M.S. et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2, 301-306 (2001).
129. Kawahata, K. et al. Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol 168, 4399-4405 (2002).
130. Lohr, J., Knoechel, B., Jiang, S., Sharpe, A.H. & Abbas, A.K. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat Immunol 4, 664-669 (2003).
131. Hsieh, C.S. et al. Recognition of the Peripheral Self by Naturally Arising CD25(+) CD4(+) T Cell Receptors. Immunity 21, 267-277 (2004).
132. Pacholczyk, R., Ignatowicz, H., Kraj, P. & Ignatowicz, L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25, 249-259 (2006).
133. Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6, 1219-1227 (2005).
134. Bruder, D. et al. On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54, 3395-3401 (2005).
135. Chen, W. et al. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198, 1875-1886 (2003).
136. Fu, S. et al. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25-precursors. Am J Transplant 4, 1614-1627 (2004).
137. Fantini, M.C. et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25-T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172, 5149-5153 (2004).
138. Kim, J.M. & Rudensky, A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 212, 86-98 (2006).
139. Peng, Y., Laouar, Y., Li, M.O., Green, E.A. & Flavell, R.A. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A 101, 4572-4577 Epub 2004 Mar 4518 (2004).
140. Park, H.B., Paik, D.J., Jang, E., Hong, S. & Youn, J. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25-T cells. Int Immunol 16, 1203-1213 Epub 2004 Jul 1205 (2004).
141. Verhasselt, V. et al. Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur J Immunol 34, 762-772 (2004).
142. Polanczyk, M.J. et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 173, 2227-2230 (2004).
143. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936-940 (2007).
144. Gavin, M.A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature (2007).
145. Williams, L.M. & Rudensky, A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8, 277-284 (2007).
146. Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10, 1969-1980 (1998).
147. Kramer, S., Schimpl, A. & Hunig, T. Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J Exp Med 182, 1769-1776 (1995).
148. Almeida, A.R., Legrand, N., Papiernik, M. & Freitas, A.A. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169, 4850-4860 (2002).
149. Suzuki, H., Zhou, Y.W., Kato, M., Mak, T.W. & Nakashima, I. Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. J Exp Med 190, 1561-1572 (1999).
150. Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253-261 (1993).
151. Suzuki, H. et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472-1476 (1995).
152. Willerford, D.M. et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530 (1995).
153. Fontenot, J.D., Rasmussen, J.P., Gavin, M.A. & Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6, 1142-1151 (2005).
154. Liston, A., Siggs, O.M. & Goodnow, C.C. Tracing the action of IL-2 in tolerance to islet-specific antigen. Immunol Cell Biol 85, 338-342 (2007).
155. Antony, P.A. et al. Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol 176, 5255-5266 (2006).
156. Yamanouchi, J. et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet (2007).
157. Podolin, P.L. et al. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine 12, 477-482. (2000).
158. Martinez, X. et al. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles. J Immunol 175, 1677-1685 (2005).
159. Fontenot, J.D., Dooley, J.L., Farr, A.G. & Rudensky, A.Y. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 202, 901-906 (2005).
160. Gough, S.C., Walker, L.S. & Sansom, D.M. CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204, 102-115 (2005).
161. Krummel, M.F. & Allison, J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183, 2533-2540 (1996).
162. Walunas, T.L., Bakker, C.Y. & Bluestone, J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 183, 2541-2550 (1996).
163. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511 (2003).
164. Hill, N.J. et al. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 49, 1744-1747. (2000).
165. Oaks, M.K. et al. A native soluble form of CTLA-4. Cell Immunol 201, 144-153 (2000).
166. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3, 1097-1101 (2002).
167. Chitale, S. & Moots, R. Abatacept: the first T lymphocyte co-stimulation modulator, for the treatment of rheumatoid arthritis. Expert Opin Biol Ther 8, 115-122 (2008).
168. Wu, K., Bi, Y., Sun, K. & Wang, C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 4, 269-275 (2007).
169. Maynard, C.L. et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol 8, 931-941 (2007).
170. Davidson, N.J. et al. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184, 241-251 (1996).
171. Rubtsov, Y.P. et al. IL-10 produced by regulatory T cells contributes to their suppressor function by limiting inflammation at environmental interfaces. Immunity 28, 546-558 (2008).
172. Mizoguchi, A. & Bhan, A.K. A case for regulatory B cells. J Immunol 176, 705-710 (2006).
173. Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D. & Anderton, S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3, 944-950 (2002).
174. Singh, A.K. et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194, 1801-1811 (2001).
175. Sharif, S. et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 7, 1057-1062 (2001).
176. Yoshimoto, T., Bendelac, A., Hu-Li, J. & Paul, W.E. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc Natl Acad Sci U S A 92, 11931-11934 (1995).
177. Baxter, A.G., Kinder, S.J., Hammond, K.J., Scollay, R. & Godfrey, D.I. Association between alphabetaTCR+CD4-CD8-T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46, 572-582 (1997).
178. Godfrey, D.I., Kinder, S.J., Silvera, P. & Baxter, A.G. Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8-thymocytes. J Autoimmun 10, 279-285. (1997).
179. Gombert, J.M. et al. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol 26, 2989-2998 (1996).
180. Poulton, L.D. et al. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol 13, 887-896 (2001).
181. Esteban, L.M. et al. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J Immunol 171, 2873-2878 (2003).
182. Hammond, K.J. et al. alpha/beta-T cell receptor (TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 187, 1047-1056 (1998).
183. Wilson, S.B. et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391, 177-181 (1998).
184. Ivanov, II, Zhou, L. & Littman, D.R. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19, 409-417 (2007).
185. Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171, 6173-6177 (2003).
186. Komiyama, Y. et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177, 566-573 (2006).
187. Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263-266 (1999).
188. Mak, T.W. et al. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat Immunol 4, 765-772 (2003).
189. Rousset, F. et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 89, 1890-1893 (1992).
190. Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483 (2007).
191. Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448, 484-487 (2007).
192. Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8, 967-974 (2007).
193. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
194. Mangan, P.R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231-234 (2006).
195. Ivanov, II et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133 (2006).
196. McGeachy, M.J. et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8, 1390-1397 (2007).
197. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201, 233-240 (2005).
198. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
199. Cargill, M. et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80, 273-290 (2007).
200. Vinuesa, C.G. et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435, 452-458 (2005).
201. Yu, D. et al. Roquin represses autoimmunity by limiting inducible T-cell costimulator messenger RNA. Nature 451, 1022 (2008).
202. Cappione, A., 3rd et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 115, 3205-3216 (2005).
203. Hutloff, A. et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum 50, 3211-3220 (2004).
204. Weant, A.E. et al. Apoptosis regulators bim and fas function concurrently to control autoimmunity and CD8(+) T cell contraction. Immunity 28, 218-230 (2008).
205. Hughes, P.D. et al. Apoptosis regulators fas and bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28, 197-205 (2008).
206. Hutcheson, J. et al. Combined Deficiency of Proapoptotic Regulators Bim and Fas Results in the Early Onset of Systemic Autoimmunity. Immunity 28, 206-217 (2008).
207. Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946 (1995).
208. Xu, L., Zhang, L., Yi, Y., Kang, H.K. & Datta, S.K. Human lupus T cells resist inactivation and escape death by upregulating COX-2. Nat Med 10, 411-415 (2004).
209. Schirmer, M., Vallejo, A.N., Weyand, C.M. & Goronzy, J.J. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28-T cells from rheumatoid arthritis patients. J Immunol 161, 1018-1025 (1998).
210. Sharief, M.K. & Semra, Y.K. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis. J Neuroimmunol 119, 358-364 (2001).
211. Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15, 289-292 (1997).
212. Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15, 293-297 (1997).
213. Giraud, M. et al. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature 448, 934-937 (2007).
214. Yamada, R. & Yamamoto, K. Mechanisms of disease: genetics of rheumatoid arthritis--ethnic differences in disease-associated genes. Nat Clin Pract Rheumatol 3, 644-650 (2007).
215. Faas, S. & Trucco, M. The genes influencing the susceptibility to IDDM in humans. J Endocrinol Invest 17, 477-495 (1994).
216. Rioux, J.D. et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39, 596-604 (2007).
217. Singh, S.B., Davis, A.S., Taylor, G.A. & Deretic, V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438-1441 (2006).
218. Nagamine, K. et al. Positional cloning of the APECED gene. Nat Genet 17, 393-398 (1997).
219. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17, 399-403 (1997).
220. Betterle, C., Greggio, N.A. & Volpato, M. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 83, 1049-1055 (1998).
221. Anderson, M.S. et al. Projection of an Immunological Self-Shadow Within the Thymus by the Aire Protein. Science 298, 1395-1401 (2002).
222. Ramsey, C. et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 11, 397-409. (2002).
223. Heino, M. et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 257, 821-825. (1999).
224. Kogawa, K. et al. Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol Lett 80, 195-198 (2002).
225. Derbinski, J. et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med 202, 33-45 (2005).
226. Liston, A., Lesage, S., Wilson, J., Peltonen, L. & Goodnow, C.C. Aire regulates negative selection of organ-specific T cells. Nat Immunol 4, 350-354 (2003).
227. DeVoss, J. et al. Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med 203, 2727-2735 (2006).
228. Liston, A. et al. Gene dosage limiting role of Aire in thymic expression, clonal deletion and organ-specific autoimmunity. J Exp Med 200, 1015-1026 (2004).
229. Heino, M. et al. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol 30, 1884-1893. (2000).
230. Rinderle, C., Christensen, H.M., Schweiger, S., Lehrach, H. & Yaspo, M.L. AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered subcellular distribution of mutants lacking the PHD zinc fingers. Hum Mol Genet 8, 277-290 (1999).
231. Pitkanen, J. et al. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem 275, 16802-16809. (2000).
232. Kumar, P.G. et al. The autoimmune regulator (AIRE) is a DNA-binding protein. J Biol Chem 276, 41357-41364 (2001).
233. Bjorses, P. et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasisectodermal dystrophy protein. Am J Hum Genet 66, 378-392. (2000).
234. Ruan, Q.G. et al. The autoimmune regulator directly controls the expression of genes critical for thymic epithelial function. J Immunol 178, 7173-7180 (2007).
235. Gillard, G.O. & Farr, A.G. Features of medullary thymic epithelium implicate postnatal development in maintaining epithelial heterogeneity and tissue-restricted antigen expression. J Immunol 176, 5815-5824 (2006).
236. Ilmarinen, T. et al. Functional interaction of AIRE with PIAS1 in transcriptional regulation. Mol Immunol 45, 1847-1862 (2008).
237. Org, T. et al. The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep (2008).
238. Tao, Y. et al. AIRE recruits multiple transcriptional components to specific genomic regions through tethering to nuclear matrix. Mol Immunol 43, 335-345 (2006).
239. Gillard, G.O., Dooley, J., Erickson, M., Peltonen, L. & Farr, A.G. Aire-dependent alterations in medullary thymic epithelium indicate a role for Aire in thymic epithelial differentiation. J Immunol 178, 3007-3015 (2007).
240. Kuroda, N. et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol 174, 1862-1870 (2005).
241. Anderson, M.S. et al. The cellular mechanism of Aire control of T cell tolerance. Immunity 23, 227-239 (2005).
242. Li, J. et al. Developmental pathway of CD4+CD8-medullary thymocytes during mouse ontogeny and its defect in Aire-/-mice. Proc Natl Acad Sci U S A 104, 18175-18180 (2007).
243. Halonen, M. et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 87, 2568-2574 (2002).
244. Kogawa, K. et al. Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associated with compound heterozygous novel AIRE gene mutations. Clin Immunol 103, 277-283 (2002).
245. Jiang, W., Anderson, M.S., Bronson, R., Mathis, D. & Benoist, C. Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med 202, 805-815 (2005).
246. Kont, V. et al. Modulation of Aire regulates the expression of tissue-restricted antigens. Mol Immunol 45, 25-33 (2008).
247. Anderson, A.C. et al. High frequency of autoreactive myelin proteolipid proteinspecific T cells in the periphery of naive mice: mechanisms of selection of the selfreactive repertoire. J Exp Med 191, 761-770 (2000).
248. Miyamoto, K., Miyake, S., Schachner, M. & Yamamura, T. Heterozygous null mutation of myelin P0 protein enhances susceptibility to autoimmune neuritis targeting P0 peptide. Eur J Immunol 33, 656-665 (2003).
249. Taubert, R., Schwendemann, J. & Kyewski, B. Highly variable expression of tissuerestricted self-antigens in human thymus: implications for self-tolerance and autoimmunity. Eur J Immunol 37, 838-848 (2007).
250. Saboori, A.M., Rose, N.R., Bresler, H.S., Vladut-Talor, M. & Burek, C.L. Iodination of human thyroglobulin (Tg) alters its immunoreactivity. I. Iodination alters multiple epitopes of human Tg. Clin Exp Immunol 113, 297-302 (1998).
251. Barin, J.G., Talor, M.V., Sharma, R.B., Rose, N.R. & Burek, C.L. Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD.H2 mouse. Clin Exp Immunol 142, 251-259 (2005).
252. Laurberg, P. et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 83, 765-769 (1998).
253. Brand, O., Gough, S. & Heward, J. HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Reviews in Molecular Medicine 7, 1-15 (2005).
254. Wicker, L.S. Major histocompatibility complex-linked control of autoimmunity. J Exp Med 186, 973-975 (1997).
255. Corper, A.L. et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288, 505-511 (2000).
256. Stratmann, T. et al. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J Immunol 165, 3214-3225 (2000).
257. Wen, L., Wong, F.S., Sherwin, R. & Mora, C. Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7. J Immunol 168, 3635-3640 (2002).
258. Li, Y. et al. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. Embo J 24, 2968-2979 (2005).
259. Maynard, J. et al. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22, 81-92 (2005).
260. Burkhardt, H. et al. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis. Arthritis Rheum 54, 82-89 (2006).
261. Nelson, G.W. et al. Cutting Edge: Heterozygote Advantage in Autoimmune Disease: Hierarchy of Protection/Susceptibility Conferred by HLA and Killer Ig-Like Receptor Combinations in Psoriatic Arthritis. J Immunol 173, 4273-4276 (2004).
262. Jones, D.C. et al. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility. Genes Immun 7, 576 (2006).
263. Ellson, C.D. et al. Neutrophils from p40phox-/-mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing. J Exp Med 203, 1927-1937 (2006).
264. Suh, C.I. et al. The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcgammaIIA receptor-induced phagocytosis. J Exp Med 203, 1915-1925 (2006).
265. Razavi, R. et al. TRPV1(+) sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 127, 1123-1135 (2006).
266. Hill, N.J. et al. Resistance of the target islet tissue to autoimmune destruction contributes to genetic susceptibility in Type 1 diabetes. Biol Direct 2, 5 (2007).
267. Li, H. et al. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes. J Clin Endocrinol Metab 86, 574-582 (2001).
268. Schernthaner, G. et al. Progress in the characterization of slowly progressive autoimmune diabetes in adult patients (LADA or type 1.5 diabetes). Exp Clin Endocrinol Diabetes 109 Suppl 2, S94-108 (2001).
269. Palmer, J.P., Hampe, C.S., Chiu, H., Goel, A. & Brooks-Worrell, B.M. Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes 54 Suppl 2, S62-67 (2005).
270. Turner, R. et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350, 1288-1293 (1997).
271. Watanabe, R.M. et al. Genetics of gestational diabetes mellitus and type 2 diabetes. Diabetes Care 30 Suppl 2, S134-140 (2007).
272. Dorner, G., Plagemann, A. & Reinagel, H. Familial diabetes aggregation in type I diabetics: gestational diabetes an apparent risk factor for increased diabetes susceptibility in the offspring. Exp Clin Endocrinol 89, 84-90 (1987).
273. McLellan, J.A. et al. Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes. Diabetologia 38, 693-698 (1995).
274. Martin, A.O., Simpson, J.L., Ober, C. & Freinkel, N. Frequency of diabetes mellitus in mothers of probands with gestational diabetes: possible maternal influence on the predisposition to gestational diabetes. Am J Obstet Gynecol 151, 471-475 (1985).
275. Kibirige, M., Metcalf, B., Renuka, R. & Wilkin, T.J. Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care 26, 2865-2870 (2003).
276. Dechairo, B.M. et al. Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 13, 1223-1230 (2005).
277. Targovnik, H.M. et al. A 138-nucleotide deletion in the thyroglobulin ribonucleic acid messenger in a congenital goiter with defective thyroglobulin synthesis. J Clin Endocrinol Metab 80, 3356-3360 (1995).
278. de Roux, N. et al. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81, 2023-2026 (1996).